Arbutus Biopharma Corp. named David Hastings as CFO, effective June 11.
Hastings takes over the CFO role from Koert VandenEnden, Arbutus' interim CFO. Hastings served as CFO and senior vice president of Unilife Corp. from 2015 to 2017 and as its chief accounting officer and treasurer from 2016 to 2017.
Burnaby, British Columbia-based Arbutus Biopharma develops and commercializes treatments for chronic hepatitis B infection.
